Resolute Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

Resolute Advisors’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-500	Closed	-$16K	–	64
2022 Q3	$16K	Hold	500	–	–	﹤0.01%	109
2022 Q2	$16K	Hold	500	–	–	﹤0.01%	102
2022 Q1	$23K	Hold	500	–	–	﹤0.01%	102
2021 Q4	$31K	Hold	500	–	–	﹤0.01%	105
2021 Q3	$37K	Buy	+500	New	+$42K	0.01%	146

Other funds holding ARKG

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Resolute Advisors's ARKG Position: Q4 2022 in Review

Resolute Advisors sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2022, closing a stake of 500 shares — an estimated $16K sold.

Resolute Advisors first reported a position in ARKG in Q3 2021 and held it in 5 quarters. The position peaked at $37K in Q3 2021. 319 funds tracked by Wall St. Rank hold ARKG as of Q4 2022.

Resolute Advisors reported no remaining ARK Genomic Revolution ETF position as of Q4 2022 after selling out during the quarter.
Resolute Advisors sold 500 ARK Genomic Revolution ETF shares in Q4 2022, an estimated $16K.
Resolute Advisors first reported a position in ARK Genomic Revolution ETF in Q3 2021 and held it in 5 quarters.
Resolute Advisors's ARK Genomic Revolution ETF position peaked at $37K in Q3 2021.
319 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2022.

Based on Resolute Advisors's 13F filing for Q4 2022, filed 10 Feb 2023.